s.coelho
TL2 · Turku
Contributes reviews on supplier material. Based in Turku.
Joined 12 August 2025 · last posted 3d
66 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #85 · Compounds › Cagrilintide & amylin analogues · 25 Jul 2026 · 0 likes Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were developed to be used together rather than instead of each other. The…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #22 · Evidence › Journal club · 22 Jul 2026 · 25 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #92 · Start Here › Welcome · 12 Jul 2026 · 0 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #52 · Nutrition & Training › Protein & intake · 11 Jul 2026 · 0 likes Where I part company with post #48, and it is a narrow parting. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with.…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #31 · Start Here › Welcome · 2 Jul 2026 · 3 likes Understood, and I withdraw the assumption I opened with.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #47 · Access › Insurance & coverage · 30 Jun 2026 · 31 likes I had written a reply contradicting post #45 and deleted it. Here is what survived. Formulary status: the list of covered medications and the tier (how much you pay)…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #32 · Research Methods › N-of-1 designs · 24 Jun 2026 · 0 likes Small correction to my own earlier position on Washout. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #135 · Access › Insurance & coverage · 21 Jun 2026 · 30 likes Two sentences on appeal and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred from…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #66 · Practice › Interactions · 17 Jun 2026 · 23 likes Adding the measurement that post #65 says would settle it. The most defensible general position in this subcategory: identify the plausible mechanism, check whether it…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #41 · Evidence › Journal club · 17 Jun 2026 · 2 likes Post #37 describes the usual case. This is about the unusual one. What I would check first on SURMOUNT-OSA is whether the thing being measured moved or whether the way…
-
Aggregate verification data across the directory, with caveats Replied, post #2 · Sourcing › Independent verification · 17 Jun 2026 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #113 · Clinical › Bloodwork · 11 Jun 2026 · 12 likes Post #111 put the caveat in the right place and I want to underline it. The most useful thing this subcategory does is help people tell an interesting result from an…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #30 · Compounds › Oral incretins · 6 Jun 2026 · 1 like Narrowing post #29, because the general version has more than one answer. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that…
-
Solubility limits and what a cloudy solution is telling you Replied, post #9 · Pharmacology › Formulation chemistry · 6 May 2026 · 20 likes Post #7 describes the usual case. This is about the unusual one. Solubility limits came up in a thread eighteen months ago and was answered well. I cannot find it,…
-
Reading a home test result without over-claiming Replied, post #21 · Analytics › Home & field testing · 24 Apr 2026 · 12 likes A test that gives a yes or no on the presence of peptide bonds is answering a genuinely useful question if that is the question you had. It is not a purity assay and…
-
Journal club: is percentage weight change the right endpoint? Replied, post #71 · Evidence › Journal club · 15 Apr 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. I would hold that…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #80 · Compounds › Tirzepatide · 12 Apr 2026 · 0 likes Adding a data point of agreement rather than a data point.
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #91 · Analytics › Mass spectrometry · 1 Apr 2026 · 18 likes Worth separating two things that post #87 runs together. A note on scope: what I am saying about Adducts applies to the case in the first post and I would not extend it…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #23 · Compounds › Semaglutide · 23 Mar 2026 · 2 likes On post #19 — agreed on the reasoning, with one qualification. Where I would push back on the molecular mass of semaglutide consensus is the confidence, not the…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #68 · Outcomes › Body composition · 15 Mar 2026 · 3 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #51 · Compounds › Cagrilintide & amylin analogues · 8 Mar 2026 · 20 likes Adding the boring version of nausea profile of amylin analogues, because the interesting version keeps getting posted and the boring one is usually right. Check the…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #58 · Practice › Storage & stability · 29 Jan 2026 · 21 likes The practical version of Storing lyophilised material long term is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
-
Micro-titration: a disputed topic, argued properly Replied, post #23 · Practice › Dosing & titration · 16 Jan 2026 · 5 likes If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure. That…
-
Second pass at: Programming during a large energy deficit Replied, post #96 · Nutrition & Training › Resistance training · 25 Nov 2025 · 3 likes The reason Programming during a large energy is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one…
-
A history of disordered eating: proceeding carefully Replied, post #8 · Wellbeing › Mental health · 19 Nov 2025 · 0 likes Posting my history of disordered eating numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who…
-
[2026 update] What steady state means for the decision to escalate Replied, post #113 · Practice › Dosing & titration · 16 Nov 2025 · 4 likes Where I part company with post #111, and it is a narrow parting. Split dosing within a week is sometimes proposed to smooth tolerability. With a week-long half-life the…
-
EMA product information as a primary source Replied, post #51 · Regional › European Union · 10 Nov 2025 · 1 like I would keep EMA product information and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #13 · Analytics › Method validation · 7 Nov 2025 · 5 likes Confirming post #12 from a second method, which matters more than confirming it from a second person. Where a pharmacopoeial monograph exists, a method that follows it…
-
Cross-border purchase rules within the EU Replied, post #33 · Regional › European Union · 3 Nov 2025 · 0 likes Post #29 and I disagree about the size of the effect, not about the direction. The public assessment report published at authorisation is one of the best free technical…
-
A 40-week log with the measurement method stated Replied, post #45 · Outcomes › Progress reports · 21 Oct 2025 · 20 likes Where I would push back on the 40-week log consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
New subcategory: rationale and scope Replied, post #56 · Meta › Announcements · 18 Oct 2025 · 18 likes Taking post #55 at face value and following it one step further. RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #69 · Compounds › Semaglutide · 4 Oct 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed semaglutide versus liraglutide, as opposed to read about it? The thread is long and I…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 21 likes Taking post #38 at face value and following it one step further. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #76 · Evidence › Preprints · 1 Oct 2025 · 1 like Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Reading SURMOUNT-1 without the press release Replied, post #15 · Compounds › Tirzepatide · 23 Sep 2025 · 3 likes Since reading SURMOUNT-1 without the press keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone…
-
A ten-fold dose error caught before injection Replied, post #101 · Devices › Syringes & needles · 16 Sep 2025 · 0 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Managing an unplanned gap in supply — what changed since Replied, post #48 · Access › Shortages · 28 Aug 2025 · 0 likes On Managing an unplanned gap I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #121 · Practice › Reconstitution · 24 Aug 2025 · 0 likes Picking up post #118: that is the part I would want checked first. Reconstituting a multi-strength kit is worth one more sentence than it usually gets, and the sentence…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #88 · Compounds › Secretagogues & GH axis · 22 Aug 2025 · 0 likes Post #85 answers the question as asked. The question underneath it is different. Why this subcategory is stricter about sourcing than most: the evidence base is weaker…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #12 · Practice › Storage & stability · 2 Aug 2025 · 1 like Picking up post #9: that is the part I would want checked first. I read the earlier replies on power cut for eleven hours twice before writing this, because I had…
-
Washout: how long is long enough, and for what purpose Replied, post #47 · Pharmacology › Pharmacokinetics · 20 Jul 2025 · 0 likes Worth separating two things that post #45 runs together. The thing about washout that took me longest to accept is that a plausible mechanism is not evidence of an…
-
Reading a supplier's product description as a marketing document Replied, post #39 · Compounds › Other compounds · 30 Jun 2025 · 8 likes Post #37 describes the usual case. This is about the unusual one. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature,…
-
Sequence verification for an obscure compound: how it is done Replied, post #77 · Compounds › Other compounds · 29 Jun 2025 · 2 likes Adding a null result on sequence verification. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #147 · Access › Insurance & coverage · 16 Jun 2025 · 0 likes Post #145 put the caveat in the right place and I want to underline it. The practical version of appeal is three sentences long. The rigorous version is three pages and…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #120 · Devices › Cold chain · 10 Jun 2025 · 25 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
An appeal that failed, and what I would do differently Replied, post #4 · Access › Insurance & coverage · 23 May 2025 · 8 likes Building on the opening post rather than restating it. A peer-to-peer review is available in many systems and is frequently more productive than a written appeal,…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #13 · Practice › Administration · 16 May 2025 · 1 like Completing a dose is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
-
Adjudicated events and why the definition matters — the long version Replied, post #141 · Evidence › Trials · 7 May 2025 · 0 likes Before the thread moves on from Adjudicated events — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 27 Apr 2025 · 1 like Fair, and the limits you put on it are the part I will remember.
-
Criticising the method without criticising the authors Replied, post #57 · Evidence › Study critique · 19 Apr 2025 · 16 likes Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered is a criticism of the field rather than of the…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #88 · Documentation › Doc review · 3 Apr 2025 · 0 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. On balance I think that is right, and I…
-
Albumin binding and how it produces a long half-life Replied, post #20 · Pharmacology › Pharmacokinetics · 1 Apr 2025 · 6 likes Where I part company with post #18, and it is a narrow parting. Nobody has said the unglamorous part of albumin binding yet, so: most of the variation is explained by…
-
Adjudicated events and why the definition matters — the long version Replied, post #33 · Evidence › Trials · 4 Mar 2025 · 3 likes Post #32 answers the question as asked. The question underneath it is different. I keep a log for Adjudicated events specifically because my memory of it turned out to…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #20 · Sourcing › Independent verification · 28 Feb 2025 · 2 likes Nothing in a verification record is a guarantee about the vial in your hand. That check is yours and nobody can do it for you.
-
Specification in the result column: why that is a meaningful error — the long version Replied, post #18 · Analytics › COA interpretation · 28 Feb 2025 · 3 likes Where I part company with post #16, and it is a narrow parting. Method identification means enough to reproduce: column chemistry, dimensions, gradient, flow,…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #25 · Access › International · 3 Feb 2025 · 13 likes This follows post #22 rather than contradicting it. Customs practice varies between entry points within the same country, which is why two people in the same…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #16 · Clinical › Bloodwork · 12 Jan 2025 · 6 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
-
What changed in 2026, by region Replied, post #68 · Access › International · 10 Jan 2025 · 32 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #129 · Compounds › Other compounds · 20 Nov 2024 · 28 likes I read post #127 twice before replying, because I had assumed the opposite. My position on Melanocortin agonists is current rather than settled. I have revised it once…
-
Converting between mg/mL and units per dose, both directions Replied, post #91 · Practice › Reconstitution · 16 Nov 2024 · 16 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #13 · Compounds › Repair & healing peptides · 8 Nov 2024 · 0 likes Reading a preclinical wound-healing model is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with…
-
A side-effect grading scheme this community uses, and its limits — the long version Replied, post #7 · Practice › Side effects · 8 Nov 2024 · 24 likes Worth separating two things that post #3 runs together. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme…
-
Converting between mg/mL and units per dose, both directions Replied, post #74 · Practice › Reconstitution · 3 Nov 2024 · 29 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #87 · Practice › Administration · 7 Oct 2024 · 7 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Irish differences from the UK position Replied, post #9 · Regional › UK & Ireland · 25 Sep 2024 · 16 likes Post #8 is right about the mechanism and I think understates the practical bit. The most useful contribution is a link to the current official page with the date you…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #38 · Evidence › Preprints · 16 Sep 2024 · 0 likes A preprint reporting a null result is more likely to stay a preprint, which biases the published literature and makes preprint servers more valuable rather than less.